drugset / Trial / NCT00353990

Bioavailability of Insulin Administered in Duodenum

NCT00353990

Non-randomizedSingle-groupSingle-blindTreatment

Summary

A study of the bioavailability of insulin after infusion in the duodenum in healthy volunteers.

Timeline

Start
2006-08
Primary completion
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Subject insulin aspart Protein / enzyme biologic 6 iu Other
Subject insulin aspart Protein / enzyme biologic 150 iu Other
Subject insulin aspart Protein / enzyme biologic 300 iu Other
Subject insulin aspart Protein / enzyme biologic 600 iu Other
Subject insulin aspart Protein / enzyme biologic 1000 iu Other

Indications